20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
National Research Corp (NRC) operates in the HEALTH INFORMATION SERVICES industry and is headquartered in Lincoln, United States with about 357 employees. Its market capitalization is roughly $506 million. In the fiscal year ended 2025-12-31, NRC reported $137M in revenue and $12M in net income.
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
Interactive charts & full statements → Open the NRC valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $140M | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | $93M | $86M | $76M | $63M | $58M | $51M | $49M | $44M |
| Gross Profit | $94M | $77M | $86M | $93M | $95M | $96M | $84M | $82M | $72M | $68M | $64M | $58M | $57M | $54M | $51M | $47M | $39M | $33M | $27M | $27M | $24M |
| Gross Margin % | 66.8% | 56.3% | 60.2% | 62.3% | 62.4% | 64.6% | 63.1% | 63.7% | 60.2% | 58.3% | 58.3% | 56.4% | 57.8% | 58.1% | 59.0% | 62.2% | 61.1% | 57.4% | 53.7% | 55.4% | 55.6% |
| Operating Income (EBIT) | $15M | $23M | $35M | $40M | $47M | $50M | $43M | $43M | $35M | $34M | $31M | $26M | $28M | $25M | $23M | $19M | $14M | $14M | $12M | $11M | $10M |
| Operating Margin % | 10.5% | 16.4% | 24.6% | 27.0% | 30.7% | 34.0% | 32.0% | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | 26.8% | 26.3% | 24.7% | 21.9% | 23.7% | 23.5% | 23.2% | 22.6% |
| Net Income | $6M | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | $15M | $15M | $12M | $8M | $8M | $7M | $7M | $6M |
| Net Margin % | 4.2% | 8.4% | 17.3% | 20.8% | 21.0% | 25.3% | 28.0% | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | 16.7% | 17.4% | 15.3% | 13.4% | 14.7% | 14.6% | 14.0% | 13.4% |
| EBITDA | $23M | $30M | $41M | $46M | $49M | $57M | $51M | $49M | $42M | $39M | $36M | $32M | $32M | $29M | $27M | $24M | $19M | $17M | $15M | $14M | $12M |
| Earnings Per Share (EPS) | $0.26 | $0.52 | $1.04 | $1.26 | $1.27 | $1.46 | $1.45 | $1.26 | $1.07 | $0.91 | $0.83 | $0.72 | $0.74 | $0.63 | $2.17 | $1.69 | $1.26 | $1.26 | $1.09 | $0.98 | $0.85 |
| Shares Outstanding (M) | 22M | 22M | 24M | 25M | 25M | 26M | 26M | 26M | 28M | 25M | 25M | 25M | 25M | 25M | 7M | 7M | 7M | 7M | 7M | 7M | 7M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | — | $35M | $35M | $35M | $35M | $34M | $34M | $37M | $36M |
| Gross Profit | — | $35M | $19M | $19M | $20M | $19M | $19M | $23M | $21M |
| Gross Margin % | — | 100.0% | 54.6% | 54.3% | 57.8% | 56.8% | 56.5% | 61.1% | 57.3% |
| Operating Income (EBIT) | — | ($3M) | $6M | $5M | $8M | $2M | $9M | $10M | $8M |
| Operating Margin % | — | -9.2% | 16.0% | 13.3% | 22.4% | 4.7% | 25.6% | 26.0% | 22.3% |
| Net Income | — | ($3M) | $3M | $2M | $4M | $0M | $6M | $7M | $6M |
| Net Margin % | — | -9.3% | 9.3% | 5.1% | 11.9% | -0.3% | 17.2% | 17.8% | 15.9% |
| EBITDA | — | ($1M) | $8M | $7M | $10M | $3M | $10M | $11M | $10M |
| Earnings Per Share (EPS) | $0.21 | $-0.15 | $0.15 | $0.08 | $0.18 | $-0.00 | $0.25 | $0.28 | $0.24 |
| Shares Outstanding (M) | — | 22M | 22M | 22M | 23M | 23M | 23M | 23M | 24M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $30M | $26M | $35M | $38M | $36M | $46M | $41M | $41M | $40M | $28M | $27M | $22M | $26M | $19M | $19M | $18M | $15M | $14M | $15M | $15M | $7M |
| Capital Expenditures (CapEx) | $8M | $11M | $15M | $16M | $10M | $6M | $4M | $5M | $6M | $5M | $4M | $3M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $2M | $1M |
| Free Cash Flow (FCF) | $22M | $16M | $19M | $22M | $26M | $41M | $37M | $36M | $34M | $23M | $23M | $19M | $24M | $17M | $17M | $16M | $13M | $11M | $12M | $13M | $5M |
| FCF Margin % | 15.5% | 11.5% | 13.4% | 15.0% | 17.4% | 27.6% | 27.5% | 28.3% | 28.3% | 19.8% | 20.9% | 18.5% | 24.0% | 18.5% | 19.4% | 20.7% | 20.6% | 18.6% | 24.2% | 25.8% | 12.2% |
| Dividends Paid | $13M | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | $10M | $2M | $17M | $6M | $5M | $4M | $4M | $3M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $1M | $7M | $7M | $14M | ($1M) | $7M | $6M | $9M |
| Capital Expenditures (CapEx) | $1M | $2M | $1M | $4M | $3M | $3M | $4M | $2M |
| Free Cash Flow (FCF) | $0M | $5M | $6M | $10M | ($4M) | $4M | $2M | $8M |
| FCF Margin % | 0.2% | 15.4% | 17.2% | 29.4% | -12.2% | 10.9% | 5.2% | 21.9% |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $136M | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $129M | $130M | $111M | $100M | $101M | $96M | $72M | $71M | $62M | $62M |
| Cash & Cash Equivalents | $3M | $4M | $4M | $7M | $25M | $54M | $35M | $14M | $13M | $35M | $33M | $42M | $40M | $22M | $8M | $8M | $4M | $3M | $1M | $3M | $1M |
| Total Liabilities | $130M | $121M | $101M | $73M | $58M | $72M | $69M | $78M | $89M | $37M | $38M | $55M | $42M | $39M | $43M | $45M | $47M | $28M | $32M | $20M | $25M |
| Total Debt (Short + Long-Term) | $90M | $79M | $63M | $37M | $23M | $28M | $32M | $34M | $38M | $1M | $4M | $6M | $8M | $10M | $13M | $15M | $16M | $8M | $13M | $3M | $11M |
| Total Shareholders' Equity | $7M | $14M | $31M | $49M | $72M | $85M | $64M | $33M | $19M | $90M | $83M | $74M | $88M | $72M | $57M | $56M | $49M | $44M | $39M | $42M | $37M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NRC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms